Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Universalis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Large-scale testing (Phase 3)Study completedNCT04006457
What this trial is testing

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 1,057
Testing effectiveness (Phase 2)Study completedNCT03594227
What this trial is testing

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Who this might be right for
Alopecia
Aclaris Therapeutics, Inc. 87
Not applicableActive Not RecruitingNCT00069589
What this trial is testing

Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+2 more
M.D. Anderson Cancer Center 3,100
Testing effectiveness (Phase 2)Study completedNCT05589610
What this trial is testing

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia AreataAlopeciaAlopecia Totalis+1 more
Equillium 36
Large-scale testing (Phase 3)Study completedNCT00063076
What this trial is testing

Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

Who this might be right for
Alopecia Areata
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT02812342
What this trial is testing

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Yale University 10
Large-scale testing (Phase 3)Study completedNCT00997815
What this trial is testing

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Who this might be right for
Recalcitrant Alopecia TotalisRecalcitrant Alopecia Universalis
Siriraj Hospital 20
Not applicableStudy completedNCT07101471
What this trial is testing

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Who this might be right for
Alopecia Totalis/UniversalisAlopecia Areata(AA)
NanoAlvand 296
Testing effectiveness (Phase 2)Study completedNCT03359356
What this trial is testing

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Who this might be right for
Alopecia Areata
Icahn School of Medicine at Mount Sinai 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Not applicableAvailableNCT05522556
What this trial is testing

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Who this might be right for
Alopecia Areata
Pfizer
Large-scale testing (Phase 3)Looking for participantsNCT06873945
What this trial is testing

2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 674
Testing effectiveness (Phase 2)Ended earlyNCT02553330
What this trial is testing

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Who this might be right for
Alopecia Areata
Incyte Corporation 90
Testing effectiveness (Phase 2)UnknownNCT04011748
What this trial is testing

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Throne Biotechnologies Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02684097
What this trial is testing

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Emma Guttman 22
Not applicableStudy completedNCT05098600
What this trial is testing

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+24 more
Faculty Hospital Kralovske Vinohrady 123
Large-scale testing (Phase 3)Study completedNCT03732807
What this trial is testing

PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 718
Not applicableLooking for participantsNCT06283316
What this trial is testing

Systemic Treatments for Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+5 more
Erasmus Medical Center 10,000
Post-approval studies (Phase 4)Study completedNCT03800979
What this trial is testing

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Who this might be right for
Alopecia Areata
Institute of Dermatology, Thailand 19
Testing effectiveness (Phase 2)Study completedNCT02197455
What this trial is testing

Tofacitnib for the Treatment of Alopecia Areata and Variants

Who this might be right for
Alopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU)
Yale University 30
Next Page